Long term treatment of pulmonary arterial hypertension with beraprost, an oral prostacyclin analogue (Q28364280)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11711462%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

title

Long term treatment of pulmonary arterial hypertension with beraprost, an oral prostacyclin analogue (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11711462%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

main subject

arterial hypertension

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11711462%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

Susanna Sciomer

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11711462%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

author name string

S Morelli

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11711462%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

C Lavalle

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11711462%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

P Di Marzio

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11711462%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

D Padovani

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11711462%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

R Badagliacca

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11711462%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

A R Vestri

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11711462%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

R Naeije

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11711462%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

F Fedele

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11711462%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

language of work or name

English

0 references

publication date

1 December 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11711462%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11711462%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

volume

86

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11711462%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11711462%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

page(s)

661-665

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11711462%20AND%20SRC:MED&resulttype=core&format=json

Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trial

3 December 2019

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1730044

Chronic thromboembolic pulmonary hypertension: clinical picture and surgical treatment

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1730044

Short-term and long-term epoprostenol (prostacyclin) therapy in pulmonary hypertension secondary to connective tissue diseases: results of a pilot study.

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1730044

Prostacyclin (epoprostenol) and heart-lung transplantation as treatments for severe pulmonary hypertension

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1730044

Primary pulmonary hypertension. A national prospective study

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1730044

Inhaled iloprost to treat severe pulmonary hypertension. An uncontrolled trial. German PPH Study Group

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1730044

Primary pulmonary hypertension: improved long-term effects and survival with continuous intravenous epoprostenol infusion

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1730044

A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1730044

General pharmacology of beraprost sodium. 2nd communication: effect on the autonomic, cardiovascular and gastrointestinal systems, and other effects.

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1730044

Long-Term Treatment of Primary Pulmonary Hypertension with Aerosolized Iloprost, a Prostacyclin Analogue

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1730044

Effect of orally active prostacyclin analogue on survival of outpatients with primary pulmonary hypertension.

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1730044

Reduction in pulmonary vascular resistance with long-term epoprostenol (prostacyclin) therapy in primary pulmonary hypertension.

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1730044

Survival in primary pulmonary hypertension with long-term continuous intravenous prostacyclin

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1730044

How should we measure function in patients with chronic heart and lung disease?

27 November 2018

1 reference

12 December 2020

Treatment of primary pulmonary hypertension with continuous intravenous prostacyclin (epoprostenol). Results of a randomized trial

1 reference

12 December 2020

Short-term hemodynamic effect of a new oral PGI2 analogue, beraprost, in primary and secondary pulmonary hypertension

1 reference

12 December 2020

Primary pulmonary hypertension

1 reference

12 December 2020

Orally active prostacyclin analogue in primary pulmonary hypertension

1 reference

12 December 2020

Additive effect of beraprost on pulmonary vasodilation by inhaled nitric oxide in children with pulmonary hypertension

1 reference

12 December 2020

Long-term prostacyclin for pulmonary hypertension with associated congenital heart defects

1 reference

12 December 2020

Compassionate use of continuous prostacyclin in the management of secondary pulmonary hypertension: a case series

1 reference

12 December 2020

Identifiers

DOI

10.1136/HEART.86.6.661

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11711462%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11711462%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

PubMed publication ID

11711462

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11711462%20AND%20SRC:MED&resulttype=core&format=json